FRANCA BAKANE: Open Payments
NPI 1376119321 · MC LEAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 31 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $253 |
| Alkermes, Inc. | 7 | $228 |
| Teva Pharmaceuticals USA, Inc. | 4 | $113 |
| Neurocrine BioSciences, Inc. | 4 | $107 |
| ABBVIE INC. | 3 | $61 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: ABILIFY MAINTENA, LYBALVI, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, UZEDY, VRAYLAR, COBENFY.
Industry payments across VA — which companies pay providers there.
